Analysts anticipate Inari Medical to report an earnings per share (EPS) of $-0.11.
Inari Medical bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings Track Record
Last quarter the company missed EPS by $0.35, which was followed by a 10.65% drop in the share price the next day.
Here's a look at Inari Medical's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
-0.13
-0.20
0.01
0
EPS Actual
-0.48
-0.33
-0.08
0.05
Price Change %
-11.0%
11.0%
-21.0%
-17.0%
Stock Performance
Shares of Inari Medical were trading at $43.96 as of October 24. Over the last 52-week period, shares are down 24.92%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analyst Observations about Inari Medical
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Inari Medical.
Inari Medical has received a total of 9 ratings from analysts, with the consensus rating as Neutral. With an ...
